Latest Glycobiology Stories
MicroVascular Health Solutions investment represents large stake in artery health technology Maastricht, The Netherlands (PRWEB) February 24, 2015 U.S.-
MONROVIA, Calif., Dec. 18, 2014 /PRNewswire/ -- Xencor, Inc.
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
Being one of the most widely-used applications of glycomics, drug discovery and development was one of the largest application segments of the global glycomics market in 2014.
DALLAS, September 30, 2014 /PRNewswire/ -- SOURCE MarketsandMarkets
Conference call to be held today at 4:30 p.m. EDT MONROVIA, Calif., March 19, 2014 /PRNewswire/ -- Xencor Inc.
Glycomics an emerging field with implications for understanding and treating human diseasesSingapore,
Diagnosing the presence of Yersinia pestis, the cause of plague, may soon be easier than ever before.
Glycoproteins are an essential part of our body: These sugar-protein hybrid molecules are what makes the protective mucus that lines our lungs and stomach.